Security key
697947109
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA)
CUSIP: 697947109
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 11,842,870
- Total 13F shares
- 8,525,488
- Share change
- +2,619,008
- Total reported value
- $534,466,075
- Put/Call ratio
- 32%
- Price per share
- $62.69
- Number of holders
- 100
- Value change
- +$183,107,977
- Number of buys
- 66
- Number of sells
- 26
Report period
Q3 2025
Institutions
100
Top holders
10
PVLA full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
PALVELLA THERAPEUTICS, INC. SEC filings
PALVELLA THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 697947109
Recent filing periods:
Top shareholders of PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kaupinen Wes |
13D/G
|
— |
15%
|
1,644,869
|
$38,555,729 | $0 | 13 Dec 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
13F
|
Company |
7.4%
|
822,400
|
$51,556,256 | +$6,766,571 | 30 Sep 2025 | |
| Samsara BioCapital, L.P. |
13D/G
|
— |
3.1%
|
339,743
|
$8,989,600 | -$8,989,600 | 30 Jun 2025 | |
| Dellora Investments LP |
13D/G
3/4/5
|
no longer 10% owner |
1.3%
|
141,079
|
$3,306,892 | $0 | 13 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
6.1%
|
722,400
|
$16,282,896 | — | 30 Jun 2025 | |
| BVF INC/IL |
13F
|
Company |
5.9%
|
696,555
|
$15,700,350 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
3.8%
|
445,615
|
$10,044,162 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.8%
|
445,052
|
$10,031,473 | — | 30 Jun 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2.9%
|
339,743
|
$7,657,807 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.7%
|
314,989
|
$7,099,852 | — | 30 Jun 2025 | |
| ADAMS STREET PARTNERS LLC |
13F
|
Company |
2.5%
|
298,986
|
$6,739,144 | — | 30 Jun 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.1%
|
250,062
|
$5,636,397 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
173,986
|
$3,922,630 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
163,809
|
$3,692,255 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
135,754
|
$3,059,895 | — | 30 Jun 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
1.1%
|
125,259
|
$2,823,338 | — | 30 Jun 2025 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.81%
|
95,615
|
$2,155,162 | — | 30 Jun 2025 | |
| Clio Asset Management LLC |
13F
|
Company |
0.77%
|
91,508
|
$2,062,590 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.72%
|
85,329
|
$1,923,316 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.69%
|
82,011
|
$1,848,528 | — | 30 Jun 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.63%
|
74,516
|
$1,679,591 | — | 30 Jun 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.59%
|
69,416
|
$1,564,637 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.56%
|
66,858
|
$1,506,979 | — | 30 Jun 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.48%
|
56,290
|
$1,268,777 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
54,503
|
$1,228,498 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.41%
|
49,077
|
$1,106,196 | — | 30 Jun 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.37%
|
43,994
|
$991,625 | — | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.37%
|
43,348
|
$977,064 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
43,149
|
$972,579 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
21,013
|
$473,633 | — | 30 Jun 2025 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.18%
|
20,911
|
$471,334 | — | 30 Jun 2025 | |
| Strid Group, LLC |
13F
|
Company |
0.15%
|
18,166
|
$409,462 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.15%
|
17,701
|
$398,981 | — | 30 Jun 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0.15%
|
17,500
|
$394,450 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.15%
|
17,384
|
$391,835 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
13,662
|
$307,942 | — | 30 Jun 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
13,542
|
$305,237 | — | 30 Jun 2025 | |
| DELTEC ASSET MANAGEMENT LLC |
13F
|
Company |
0.11%
|
12,500
|
$281,750 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
12,179
|
$274,514 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
9,956
|
$224,401 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.08%
|
8,905
|
$200,719 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
6,066
|
$136,727 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
4,900
|
$110,446 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.04%
|
4,630
|
$104,360 | — | 30 Jun 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.04%
|
4,260
|
$96,020 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
4,174
|
$94,081 | — | 30 Jun 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
3,750
|
$84,525 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
3,665
|
$82,609 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
3,245
|
$73,143 | — | 30 Jun 2025 | |
| Spire Wealth Management |
13F
|
Company |
0.02%
|
2,516
|
$56,711 | — | 30 Jun 2025 |
Institutional Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA) as of Q3 2025
As of 30 Sep 2025,
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,525,488 shares.
The largest 10 holders included
BVF INC/IL, SUVRETTA CAPITAL MANAGEMENT, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, VANGUARD GROUP INC, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, Woodline Partners LP, FEDERATED HERMES, INC., and Point72 Asset Management, L.P..
This page lists
100
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
64
Q3 2025 holders
100
Holder diff
36
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.